The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for G21 sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
G21 is a medical equipment company that designs and manufactures orthopaedic and minimally invasive spine surgery devices. The company’s product portfolio includes bone cement, bone cement mixing devices and injections, kyphoplasty devices, and other custom-made devices. The company markets products worldwide. G21 is headquartered in San Possidonio, Emilia-Romagna, the US.
The key metrics of G21 related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As G21 is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as G21.
For a detailed understanding of the performance of G21, buy the report here.